Stay updated on Ziftomenib in AML Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib in AML Clinical Trial page.

Latest updates to the Ziftomenib in AML Clinical Trial page
- Check5 days agoChange DetectedThe footer now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link is removed, with Revision: v3.3.2 also deleted.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe history now shows a new revision tag v3.3.2 in the record, and v3.3.1 is listed as deleted; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed in the page history, reflecting a minor label update in the footer/history section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRecord history now includes Contacts/Locations and Study Status updates (version 64, 2025-11-10); the outdated government funding notice has been removed.SummaryDifference0.6%

- Check56 days agoChange DetectedOld and new screenshots show the same Record History page with no new or modified study data; the changes appear limited to layout and styling adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference8%

Stay in the know with updates to Ziftomenib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib in AML Clinical Trial page.